小胶质细胞
神经科学
纹状体
冲程(发动机)
医学
病变
运动前神经元活动
生物
炎症
病理
多巴胺
内科学
机械工程
工程类
作者
Takashi Irie,Takao Matsuda,Yoshinori Hayashi,Akihide Kamiya,Jun‐ichi Kira,Kinichi Nakashima
标识
DOI:10.1101/2021.09.26.461831
摘要
Abstract Ischaemic brain injury causes permanent neuronal loss, which often results in persistent severe neurological dysfunctions. Although generating new neurons in the injured brain would be an ideal approach to replenish the lost neurons for repairing the damage, the adult mammalian brain retains only limited neurogenic capability. Here, we show that direct conversion of microglia/macrophages into neurons in the brain has great potential as a therapeutic strategy for ischaemic brain injury. After transient middle cerebral artery occlusion in adult mice, microglia/macrophages converge at the lesion core of the striatum, where neuronal loss is prominent. Targeted expression of a neurogenic transcription factor, NeuroD1, in microglia/macrophages in the injured striatum enables their conversion into induced neuronal cells that functionally integrate into the existing neuronal circuits. Furthermore, NeuroD1-mediated induced neuronal cell generation significantly improves neurological function in the mouse stroke model, and ablation of these cells abolishes the gained functional recovery. Our findings thus demonstrate that neuronal conversion contributes directly to functional recovery after stroke and shed further light on the development of therapies for ischaemic brain injury by in situ neuronal conversion technology.
科研通智能强力驱动
Strongly Powered by AbleSci AI